These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8109935)

  • 1. Influence of local radiotherapy on penetration of fluconazole into human saliva.
    Oliary J; Tod M; Louchahi K; Petitjean O; Frachet B; Le Gros V; Brion N
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2674-7. PubMed ID: 8109935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of fluconazole in saliva and plasma after administration of an oral suspension and capsules.
    Koks CH; Meenhorst PL; Hillebrand MJ; Bult A; Beijnen JH
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1935-7. PubMed ID: 8843308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis.
    Force RW; Nahata MC
    Ann Pharmacother; 1995 Jan; 29(1):10-5. PubMed ID: 7711339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changes in irradiated salivary gland function of patients with head and neck tumors treated with radiotherapy.
    Someya M; Sakata K; Nagakura H; Nakata K; Oouchi A; Hareyama M
    Jpn J Clin Oncol; 2003 Jul; 33(7):336-40. PubMed ID: 12949059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scintigraphic assessment of salivary function and excretion response in radiation-induced injury of the major salivary glands.
    Valdés Olmos RA; Keus RB; Takes RP; van Tinteren H; Baris G; Hilgers FJ; Hoefnagel CA; Balm AJ
    Cancer; 1994 Jun; 73(12):2886-93. PubMed ID: 8199984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic optimization of the treatment of oral candidiasis with fluconazole: studies with a suspension.
    Laufen H; Yeates RA; Zimmermann T; de los Reyes C
    Drugs Exp Clin Res; 1995; 21(1):23-8. PubMed ID: 7796709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can fluconazole concentrations in saliva be used for therapeutic drug monitoring?
    Koks CH; Crommentuyn KM; Hoetelmans RM; Mathôt RA; Beijnen JH
    Ther Drug Monit; 2001 Aug; 23(4):449-53. PubMed ID: 11477332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new pharmaceutical concept for the treatment of oropharyngeal and oesophageal candidosis with fluconazole.
    Wildfeuer A; Laufen H; Yeates RA; Zimmermann T
    Mycoses; 1996; 39(9-10):357-60. PubMed ID: 9009658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of pilocarpine and biperiden on salivary secretion during and after radiotherapy in head and neck cancer patients.
    Rode M; Smid L; Budihna M; Soba E; Rode M; Gaspersic D
    Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):373-8. PubMed ID: 10487558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
    Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new pharmaceutical concept for the therapy of oropharyngeal and esophageal candidiasis with fluconazole].
    Wildfeuer A; Laufen H; Yeates RA; Zimmermann T
    Mycoses; 1996; 39 Suppl 1():123-6. PubMed ID: 8767284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluconazole concentrations in saliva from AIDS patients with oropharyngeal candidosis refractory to treatment with fluconazole.
    Garcia-Hermoso D; Dromer F; Improvisi L; Provost F; Dupont B
    Antimicrob Agents Chemother; 1995 Mar; 39(3):656-60. PubMed ID: 7793868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat salivary gland function after fractionated irradiation.
    Funegård U; Johansson I; Franzén L; Ericson T; Nyström H; Henriksson R
    Acta Oncol; 1997; 36(2):191-8. PubMed ID: 9140437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: a two-year follow up.
    Sim C; Soong YL; Pang E; Lim C; Walker GD; Manton DJ; Reynolds EC; Wee J
    Aust Dent J; 2018 Jun; 63(2):217-223. PubMed ID: 29569726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
    Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
    Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Normal tissue tolerance to external beam radiation therapy: salivary glands].
    Ortholan C; Benezery K; Bensadoun RJ
    Cancer Radiother; 2010 Jul; 14(4-5):290-4. PubMed ID: 20609609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral pH changes due to salivary gland irradiation during radiation therapy of oral and head and neck cancer.
    Viswanath L; Bhanumathi G; Reddy BK; Prabhakaran PS
    Indian J Dent Res; 2004; 15(4):137-8. PubMed ID: 16035642
    [No Abstract]   [Full Text] [Related]  

  • 18. Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer.
    van Luijk P; Pringle S; Deasy JO; Moiseenko VV; Faber H; Hovan A; Baanstra M; van der Laan HP; Kierkels RG; van der Schaaf A; Witjes MJ; Schippers JM; Brandenburg S; Langendijk JA; Wu J; Coppes RP
    Sci Transl Med; 2015 Sep; 7(305):305ra147. PubMed ID: 26378247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary flow rates in patients with head and neck cancer 0.5 to 25 years after radiotherapy.
    Liu RP; Fleming TJ; Toth BB; Keene HJ
    Oral Surg Oral Med Oral Pathol; 1990 Dec; 70(6):724-9. PubMed ID: 2263329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parotid saliva composition during and after irradiation of head and neck cancer.
    Funegård U; Franzén L; Ericson T; Henriksson R
    Eur J Cancer B Oral Oncol; 1994 Jul; 30B(4):230-3. PubMed ID: 7524881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.